Kudos, a platform for research dissemination, has announced a partnership with Oxford PharmaGenesis, a global provider of health science communications. The collaboration is designed to assist pharmaceutical, biotechnology, and healthcare organizations in developing more structured approaches to omnichannel communication strategies.
The partnership integrates Oxford PharmaGenesis’ expertise in medical content development and strategic planning with the capabilities of the Kudos platform, which includes microsite generation and analytics tools. The combined offering enables delivery of evidence-based resources such as plain language summaries, clinical trial data, infographics, videos, and prescribing information to professional and public audiences including healthcare providers, researchers, and patients.
Through the Oxford PharmaGenesis serviced edition of the Kudos platform, clients will have access to a full-service model supporting the creation, distribution, and evaluation of medical communications. The platform includes planning and management tools, along with metrics to assess reach and engagement across channels.
The initiative is intended to address the fragmentation often observed in medical affairs communication workflows by consolidating content strategy and delivery within a unified framework. It supports a range of use cases, from individual product communications by smaller biotechnology firms to large-scale content orchestration by multinational pharmaceutical companies.
The collaboration also aims to enhance understanding of audience engagement. By integrating Kudos’ platform analytics with Oxford PharmaGenesis’ qualitative methodologies and proprietary tools, the initiative will offer insights into content consumption patterns and their potential influence on perception, behavior, and clinical decision-making.
Click here to read the original press release.
